IDiyas

For the Inventor, By the Inventor

Beijing, China

Hongjun Wang

USPTO Granted Patents = 25 

 

Average Co-Inventor Count = 6.3

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:

goldMedal15 out of 17 
 
Beijing Tide Pharmaceutical Co., Ltd.
 patents
silverMedal7 out of 18,140 
 
Boe Technology Group Co., Ltd.
 patents
bronzeMedal6 out of 1,470 
 
Hefei Xinsheng Optoelectronics Technology Co., Ltd.
 patents
4. 2 out of 2,520 
 
Chengdu Boe Optoelectronics Technology Co., Ltd.
 patents
5. 1 out of 143 
 
Beijing Institute of Technology
 patents
6. 1 out of 20 
 
Boe Technology Group
 patents
7. 1 out of 17 
 
Beijing Information Science & Technology University
 patents
where one patent can have more than one assignee

Years Active: 2019-2025

where 'Filed Patents' based on already Granted Patents

25 patents (USPTO):
1. 12485108 - Method for treating fatty liver disease and/or steatohepatitis (2025-12-02),
2. 12459917 - Salt of diaminopyrimidine compounds, and solid form thereof, preparation method therefor and use thereof (2025-11-04),
3. 12410192 - Compound for inhibiting and inducing degradation of EGFR kinase (2025-09-09),
4. 12398118 - Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and use thereof (2025-08-26),
5. 12365665 - Solid form of diaminopyrimidine compound or hydrate thereof, preparation method therefor, and application thereof (2025-07-22),
6. 12326637 - Array substrate, method for manufacturing same, and display device (2025-06-10),
7. 12180243 - Receptor inhibitor, pharmaceutical composition comprising same, and use thereof (2024-12-31),
8. 11988927 - Array substrate, method for manufacturing same, and display device (2024-05-21),
9. 11939578 - Double-stranded RNA molecule targeting CKIP-1 and use thereof (2024-03-26),
10. 11919918 - P2X3 andor P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof (2024-03-05),
11. 11905274 - Receptor inhibitors, pharmaceutical compositions comprising the same and use thereof (2024-02-20),
12. 11712820 - Injection molding method for degradable intravascular stent with flexible mold core structure (2023-08-01),
13. 11453690 - Receptor inhibitor, pharmaceutical composition comprising same, and use thereof (2022-09-27),
14. 11414444 - P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof (2022-08-16),
15. 11390609 - Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and preparation method and use thereof (2022-07-19),

Title: The Innovative Journey of Hongjun Wang

Introduction: Hongjun Wang is a pioneering inventor hailing from Beijing, China, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Wang's most recent patents focus on advancements in artificial intelligence algorithms for autonomous vehicles, revolutionizing the way we approach transportation and safety on the roads.

Career Highlights: With a career spanning over two decades, Wang has held key positions in leading tech companies, where he spearheaded research and development projects that have resulted in numerous patents and technological breakthroughs.

Collaborations: Wang has collaborated with top research institutions and universities worldwide, fostering a culture of innovation and knowledge-sharing that has led to the development of cutting-edge technologies in various sectors.

Conclusion: Hongjun Wang's relentless pursuit of innovation and his commitment to pushing the boundaries of technology have solidified his reputation as a visionary inventor in the global tech community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…